We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$19.8B
AUM Growth
+$142M
Cap. Flow
-$515M
Cap. Flow %
-2.6%
Top 10 Hldgs %
32.72%
Holding
349
New
12
Increased
106
Reduced
177
Closed
17

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$154M
2
ABBV icon
AbbVie
ABBV
+$153M
3
TEL icon
TE Connectivity
TEL
+$103M
4
JNJ icon
Johnson & Johnson
JNJ
+$52.1M
5
ACN icon
Accenture
ACN
+$50.8M

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$163M
2
TRV icon
Travelers Companies
TRV
+$135M
3
PEP icon
PepsiCo
PEP
+$117M
4
TXN icon
Texas Instruments
TXN
+$107M
5
MRK icon
Merck
MRK
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.93%
2 Financials 16.28%
3 Healthcare 14.28%
4 Industrials 11.17%
5 Consumer Staples 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$367B
$212M 1.07%
680,777
+403,729
+146% +$154M
MRK icon
27
Merck
MRK
$317B
$193M 0.98%
2,435,932
-1,304,663
-35% -$104M
PEP icon
28
PepsiCo
PEP
$189B
$191M 0.97%
1,445,890
-871,884
-38% -$117M
CTAS icon
29
Cintas
CTAS
$80.9B
$175M 0.88%
784,607
-42,608
-5% -$9.17M
CINF icon
30
Cincinnati Financial
CINF
$27.5B
$174M 0.88%
1,170,415
+739
+0.1% +$106K
ACN icon
31
Accenture
ACN
$105B
$174M 0.88%
581,902
+166,688
+40% +$50.8M
CME icon
32
CME Group
CME
$95B
$171M 0.86%
619,473
-11,067
-2% -$3.01M
TRGP icon
33
Targa Resources
TRGP
$57.6B
$171M 0.86%
979,794
+47,354
+5% +$7.95M
CSCO icon
34
Cisco
CSCO
$476B
$167M 0.85%
2,411,327
+276,540
+13% +$17M
ITW icon
35
Illinois Tool Works
ITW
$84.8B
$165M 0.84%
667,602
-10,554
-2% -$2.55M
TJX icon
36
TJX Companies
TJX
$179B
$165M 0.83%
1,332,784
+7,395
+0.6% +$938K
MSI icon
37
Motorola Solutions
MSI
$78.7B
$164M 0.83%
390,119
+1,253
+0.3% +$524K
XOM icon
38
ExxonMobil
XOM
$642B
$155M 0.78%
1,435,215
+253,221
+21% +$27.1M
AAPL icon
39
Apple
AAPL
$4.56T
$153M 0.77%
744,773
-14,828
-2% -$2.99M
KDP icon
40
Keurig Dr Pepper
KDP
$41.3B
$140M 0.71%
4,224,469
-28,337
-0.7% -$958K
PPL
41
PPL Corp
PPL
$26B
$139M 0.7%
4,093,334
+120,537
+3% +$4.2M
KMI icon
42
Kinder Morgan
KMI
$69.7B
$138M 0.7%
4,706,989
-1,449
-0% -$39.8K
ABT icon
43
Abbott
ABT
$187B
$132M 0.67%
969,054
+2,166
+0.2% +$286K
GLW icon
44
Corning
GLW
$135B
$130M 0.66%
2,474,719
-77,343
-3% -$3.62M
RTX icon
45
RTX Corp
RTX
$301B
$127M 0.64%
868,966
+86,415
+11% +$11.5M
TSM icon
46
TSMC
TSM
$2.17T
$125M 0.64%
554,077
+17,164
+3% +$3.18M
EVR icon
47
Evercore
EVR
$12B
$125M 0.63%
464,592
+17,056
+4% +$3.75M
WSO icon
48
Watsco Inc
WSO
$13.2B
$123M 0.62%
278,036
-12,291
-4% -$5.7M
KO icon
49
Coca-Cola
KO
$374B
$121M 0.61%
1,714,561
+105,372
+7% +$7.51M
USB icon
50
US Bancorp
USB
$99.4B
$118M 0.6%
2,607,249
-82,316
-3% -$3.46M

Similar funds

Bahl & Gaynor's Q2 2025 Portfolio in Review

As of Q2 2025, Bahl & Gaynor held 349 positions worth $19.8B, up 0.72% from $19.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bahl & Gaynor's Q2 2025 filing shows 12 new, 106 increased, 177 reduced and 17 closed positions. Its largest new stake was AvalonBay Communities: 245,420 shares worth $49.9M. The largest sale was Williams Companies, an estimated $163M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q2 2025 buy was AvalonBay Communities: 245,420 shares worth $49.9M.
  • Bahl & Gaynor added most to UnitedHealth in Q2 2025, an estimated $154M increase.
  • Bahl & Gaynor's biggest Q2 2025 reduction was Williams Companies, cutting an estimated $163M.
  • Bahl & Gaynor fully exited United Parcel Service in Q2 2025, selling an estimated $13.9M.
  • Bahl & Gaynor's ten largest holdings make up 33% of its $19.8B portfolio in Q2 2025.
  • Bahl & Gaynor opened 12 new positions and closed 17 in Q2 2025.
  • Bahl & Gaynor's portfolio value rose 0.72% quarter-over-quarter to $19.8B.

Based on Bahl & Gaynor's 13F filing for Q2 2025, filed 12 Aug 2025.